NFKB1 and neoplasm: These findings provide a novel direction for a rational usage of anti-cancer drugs and help to establish more effective anti-tumor programs such as adjusting the dosage or combining anti-cancer drugs with inhibitors of the associated signaling pathways, such as NF-κB inhibitors.